ROBERT GUNST

Corporate Board Profile

Tech Score: 0/100

IRIDEX CORP

Filing Date	Source Excerpt
2019-06-12	Mr. Gunst has served on the Board of Directors of Natus Medical from June 2004 to June 2019, serving as the Chairman from September 2004 until July 2018. Mr. Gunst is independent and brings to the Board nearly five decades of leadership, strategy, financial and operational experience.
2020-04-27	Robert A. Gunst Mr. Gunst has served as a director of the Company since July 2019 and has served as Chairman of the Board since October 2019. Mr. Gunst is independent and brings to the Board five decades of leadership, strategy, financial and operational experience. His education and experience make Mr. Gunst uniquely qualified to serve as Chairman of the Board, as a member of our Audit Committee, and as Chairman of our Nominating and Governance Committee. Director Compensation for 2019: Robert Gunst Fees Earned or Paid in Cash ($) 24,027 Stock Awards ($) 49,998 Option Awards ($) 22,122 Total ($) 96,147

Filing Date

Source Excerpt

2019-06-12

Mr. Gunst has served on the Board of Directors of Natus Medical from June 2004 to June 2019, serving as the Chairman from September 2004 until July 2018. Mr. Gunst is independent and brings to the Board nearly five decades of leadership, strategy, financial and operational experience.

2020-04-27

Robert A. Gunst Mr. Gunst has served as a director of the Company since July 2019 and has served as Chairman of the Board since October 2019. Mr. Gunst is independent and brings to the Board five decades of leadership, strategy, financial and operational experience. His education and experience make Mr. Gunst uniquely qualified to serve as Chairman of the Board, as a member of our Audit Committee, and as Chairman of our Nominating and Governance Committee. Director Compensation for 2019: Robert Gunst Fees Earned or Paid in Cash ($) 24,027 Stock Awards ($) 49,998 Option Awards ($) 22,122 Total ($) 96,147

Data sourced from SEC filings. Last updated: 2026-02-08